NIPH Clinical Trials Search

UMIN ID: UMIN000000724

Registered date:01/06/2007

Research study of QOL with leukotriene receptor antagonist ,pranlukast in asthmatic patients by use of Asthma Health Questionnaire-Japan QOL (AHQ-JAPAN QOL)

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedAsthma
Date of first enrollment2004/10/01
Target sample size1500
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Pranlukast 2 tablets x 2 / day (112.5mg/tablet) 8 weeks


Primary OutcomeQOL Questionnaire of asthmatic patients by use of AHQ-JAPAN QOL and AQLQ.
Secondary OutcomePulmonary functions test((PEF,FVC and FEV)

Key inclusion & exclusion criteria

Age minimum16years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaAsthmatic patients with leukotoriene antagonists other than pranlukast.

Related Information


public contact
Name Hiroko Arioka
Address 1-21-1,Toyama,Shinjuku-ku ,Tokyo,162-8655,Japan Japan
Telephone 03-3202-7181
Affiliation International Medical Center of Japan Department of Respiratory Disease
scientific contact
Name Terumasa Miyamoto
Address 7-3-1 ,Hongo, Bunkyo-ku, Tokyo,113-8655,JAPAN Japan
Affiliation Professor Emeritus, University of Tokyo Department of internal medicine